<?xml version="1.0" encoding="UTF-8"?>
<ref id="B115-pharmaceuticals-13-00096">
 <label>115.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kosyna</surname>
    <given-names>F.K.</given-names>
   </name>
   <name>
    <surname>Nagel</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Kluxen</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Kraushaar</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Depping</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>The importin alpha/beta-specific inhibitor Ivermectin affects HIF-dependent hypoxia response pathways</article-title>
  <source>Biol. Chem.</source>
  <year>2015</year>
  <volume>396</volume>
  <fpage>1357</fpage>
  <lpage>1367</lpage>
  <pub-id pub-id-type="doi">10.1515/hsz-2015-0171</pub-id>
  <pub-id pub-id-type="pmid">26351913</pub-id>
 </element-citation>
</ref>
